Cardiol Therapeutics Inc. - CRDL

About Gravity Analytica
Recent News
- 05.29.2025 - Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
- 05.27.2025 - Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT
- 04.29.2025 - Cardiol Therapeutics Nominates Dr. Timothy Garnett to its Board of Directors
- 04.16.2025 - Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
- 04.01.2025 - Cardiol Therapeutics Announces Year-End 2024 Update on Operations
Recent Filings
- 05.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.29.2025 - EX-99.1 EX-99.1
- 05.27.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.27.2025 - EX-99.1 EX-99.1
- 05.14.2025 - EX-99.1 EX-99.1
- 05.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 04.29.2025 - EX-99.1 EX-99.1
- 04.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 04.28.2025 - EX-99.1 EX-99.1
- 04.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]